These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 345134)

  • 1. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
    van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
    Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind comparison of quarter strength clobetasol propionate in Unguentum Merck with betamethasone valerate in psoriasis.
    Stankler L
    Br J Clin Pract; 1983; 37(11-12):389-91. PubMed ID: 6367795
    [No Abstract]   [Full Text] [Related]  

  • 3. [Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
    Beck M; Berger C; Filipp N; Hundertmark U; Loewel R
    Z Hautkr; 1981 Aug; 56(16):1066-70. PubMed ID: 7027655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
    Gomez EC; Kaminester L; Frost P
    Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two application schedules for clobetasol 17 propionate.
    vd Harst LC; de Jonge H; Pot F; Polano MK
    Acta Derm Venereol; 1982; 62(3):270-3. PubMed ID: 6179380
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of clobetasol propionate and betamethasone-17,21-dipropionate with reference to adrenal suppression.
    Eriksen K
    Acta Derm Venereol; 1979; 59(4):372-4. PubMed ID: 92159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent topical treatment of psoriasis with clobetasol propionate ("Dermovate").
    Svartholm H; Larsson L; Frederiksen B
    Curr Med Res Opin; 1982; 8(3):154-7. PubMed ID: 6751703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the efficacy and adrenal effects of Diprolene ointment 0.05 percent and Dermovate ointment 0.05 percent in patients with psoriasis or other resistant dermatoses.
    Gip L; Hamfelt A
    Cutis; 1984 Feb; 33(2):215-7, 220-2, 224. PubMed ID: 6365474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clobetasol--a potent new topical corticosteroid.
    Med Lett Drugs Ther; 1986 Jun; 28(715):57-9. PubMed ID: 3520267
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
    Jacobson C; Cornell RC; Savin RC
    Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of betamethasone dipropionate lotion with salicylic acid (Diprosalic) and clobetasol propionate lotion (Dermovate) in the treatment of psoriasis of the scalp.
    Hillström L; Pettersson L; Svensson L
    J Int Med Res; 1982; 10(6):419-22. PubMed ID: 7152080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids.
    Walsh P; Aeling JL; Huff L; Weston WL
    J Am Acad Dermatol; 1993 Sep; 29(3):501-3. PubMed ID: 8349876
    [No Abstract]   [Full Text] [Related]  

  • 13. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
    [No Abstract]   [Full Text] [Related]  

  • 14. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison between a new trihalogenated dermatocorticosteroid (halometasone) cream and clobetasol 17-propionate (Dermovate) cream.
    Schwarz KJ; Konzelmann M; Yawalkar SJ; Schoenenberger PM
    Br J Clin Pract; 1982 May; 36(5):192-6. PubMed ID: 6756453
    [No Abstract]   [Full Text] [Related]  

  • 16. Superpotent topical steroid treatment of psoriasis vulgaris--clinical efficacy and adrenal function.
    Katz HI; Hien NT; Prawer SE; Mastbaum LI; Mooney JJ; Samson CR
    J Am Acad Dermatol; 1987 Apr; 16(4):804-11. PubMed ID: 3553247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis.
    Stein L
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S39-49. PubMed ID: 15968263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of a multicenter double-blind study in patients with resistant psoriasis and atopic dermatitis. Diprolene ointment vs. Dermovate ointment].
    Blum G; Kröpfli P; Küng D; Suter H
    Ther Umsch; 1984 Jun; 41(6):420-4. PubMed ID: 6379974
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of diflorasone diacetate and clobetasol-17-propionate in PUVA-resistant psoriasis].
    Rozman TA; Wiedey KD; Renovanz HD
    Z Hautkr; 1983 Mar; 58(6):398-409. PubMed ID: 6342288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of clobetasol dipropionate and betamethasone dipropionate].
    Rozzoni M; Tribbia G; Reseghetti A; Bassi R
    G Ital Dermatol Venereol; 1982; 117(5):LXV-LXIX. PubMed ID: 6764916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.